Análisis coste-efectividad de dasatinib frente a imatinib a dosis alta en el tratamiento de la leucemia mieloide crónica en pacientes resistentes a dosis estándar de imatinib
{"title":"Análisis coste-efectividad de dasatinib frente a imatinib a dosis alta en el tratamiento de la leucemia mieloide crónica en pacientes resistentes a dosis estándar de imatinib","authors":"J. Darbá, Lisette Kaskens","doi":"10.1007/BF03320875","DOIUrl":null,"url":null,"abstract":"","PeriodicalId":101511,"journal":{"name":"PharmacoEconomics Spanish Research Articles","volume":"54 1","pages":"0"},"PeriodicalIF":0.0000,"publicationDate":"2012-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"PharmacoEconomics Spanish Research Articles","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1007/BF03320875","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
求助内容：
应助结果提醒方式：
京公网安备 11010802042870号
